Claire Adams

University of Plymouth

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Gyorgy Fejer

University of Plymouth

UNITED KINGDOM

View details

Michael Jenkinson

Reader in Neurosurgery

University of Liverpool

UNITED KINGDOM

View details

Clemens Oliver Hanemann

University of Plymouth

UNITED KINGDOM

View details

David B Parkinson

University of Plymouth

UNITED KINGDOM

View details

Kathreena M Kurian

University of Bristol

UNITED KINGDOM

View details

Waldemar Woznica

University of Plymouth

UNITED KINGDOM

View details

Matthew Banton

University of Plymouth

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claire Adams

Research Interests

Explore related searches

Contact this professor

Articles (12)

Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas

Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics

Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours

CIRCULATING PROGNOSTIC BIOMARKERS IN MENINGIOMA: S100A4 AND FIBULIN-2

INTEGRATIVE ANALYSIS OF DIFFERENTIALLY REGULATED PROTEINS IN MENINGIOMA

A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas

miR-497 and 219 in blood aid meningioma classification

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.

A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours.

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells

The potential of mln3651 in combination with selumetinib as a treatment for merlin-deficient meningioma

Collaborators (7)

Gyorgy Fejer

Michael Jenkinson

Clemens Oliver Hanemann

David B Parkinson

Kathreena M Kurian

Waldemar Woznica

Matthew Banton

Make your next move.